Iovance Biotherapeutics: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
Iovance Biotherapeutics (NASDAQ:IOVA) reported Q4 earnings with an EPS of $-0.45, missing estimates by -5.0%. Revenue increased by $482 thousand from the previous year. The company's past earnings miss led to a 3.0% share price drop the following day.
February 28, 2024 | 9:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Iovance Biotherapeutics reported a Q4 EPS of $-0.45, missing estimates by -5.0%, with a revenue increase of $482 thousand YOY. Previous earnings miss resulted in a 3.0% stock price drop.
The reported earnings miss by -5.0% and the historical context of a stock price drop following the last earnings miss suggest a potential short-term negative impact on IOVA's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100